We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Growth Stocks to Buy for September 24th
Read MoreHide Full Article
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 24th:
Crocs, Inc. (CROX - Free Report) : This designer and distributer of casual lifestyle footwear and accessories for men, women, and children, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Target Corporation (TGT - Free Report) : This general merchandise retailer, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.2% over the last 60 days.
JD.com, Inc. (JD - Free Report) : This e-commerce company and retail infrastructure service provider, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.8% over the last 60 days.
Limbach Holdings, Inc. (LMB - Free Report) : This provider of commercial specialty contract services, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Growth Stocks to Buy for September 24th
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 24th:
Crocs, Inc. (CROX - Free Report) : This designer and distributer of casual lifestyle footwear and accessories for men, women, and children, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Crocs, Inc. Price and Consensus
Crocs, Inc. price-consensus-chart | Crocs, Inc. Quote
Crocs has a PEG ratio of 1.37, compared with 2.43 for the industry. The company possesses a Growth Score of A.
Crocs, Inc. PEG Ratio (TTM)
Crocs, Inc. peg-ratio-ttm | Crocs, Inc. Quote
Target Corporation (TGT - Free Report) : This general merchandise retailer, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.2% over the last 60 days.
Target Corporation Price and Consensus
Target Corporation price-consensus-chart | Target Corporation Quote
Target has a PEG ratio of 2.98, compared with 5.11 for the industry. The company possesses a Growth Score of A.
Target Corporation PEG Ratio (TTM)
Target Corporation peg-ratio-ttm | Target Corporation Quote
JD.com, Inc. (JD - Free Report) : This e-commerce company and retail infrastructure service provider, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.8% over the last 60 days.
JD.com, Inc. Price and Consensus
JD.com, Inc. price-consensus-chart | JD.com, Inc. Quote
JD.com has a PEG ratio of 1.00, compared with 21.26 for the industry. The company possesses a Growth Score of A.
JD.com, Inc. PEG Ratio (TTM)
JD.com, Inc. peg-ratio-ttm | JD.com, Inc. Quote
Limbach Holdings, Inc. (LMB - Free Report) : This provider of commercial specialty contract services, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Limbach Holdings, Inc. Price and Consensus
Limbach Holdings, Inc. price-consensus-chart | Limbach Holdings, Inc. Quote
Limbach has a PEG ratio of 1.14, compared with 2.87 for the industry. The company possesses a Growth Score of A.
Limbach Holdings, Inc. PEG Ratio (TTM)
Limbach Holdings, Inc. peg-ratio-ttm | Limbach Holdings, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Growth score and how it is calculated here.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>